Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trial

被引:52
|
作者
von Blanckenburg, Pia [1 ]
Schuricht, Franziska [1 ]
Albert, Ute-Susann [2 ]
Rief, Winfried [1 ]
Nestoriuc, Yvonne [3 ]
机构
[1] Univ Marburg, Dept Clin Psychol & Psychotherapy, D-35032 Marburg, Germany
[2] Univ Marburg, Breast Canc Ctr, Dept Gynecol Gynecol Endocrinol & Oncol, D-35032 Marburg, Germany
[3] Univ Hamburg, Dept Clin Psychol, Hamburg, Germany
关键词
Nocebo; Side effects; Prevention; Breast cancer; Endocrine therapy; RCT; ADJUVANT HORMONAL-THERAPY; EUROPEAN-ORGANIZATION; POSTMENOPAUSAL WOMEN; MENOPAUSAL SYMPTOMS; COMBINATION TRIAL; CLINICAL-TRIALS; ATAC ARIMIDEX; SHORT-FORM; ADHERENCE; QUESTIONNAIRE;
D O I
10.1186/1471-2407-13-426
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Adjuvant endocrine therapy can improve disease-free survival and time before recurrence in breast cancer patients. However, it is associated with considerable side effects that negatively affect patients' quality of life and cause non-adherence. The recently demonstrated effect of individual expectations on side-effect development (nocebo effect) suggests that psychological factors play a role in the prevention of side effects. The aim of this study is to evaluate cognitive-behavioral side-effect prevention training (SEPT) for breast cancer patients. This article describes the study protocol and applied research methods. Methods/Design: In a randomized controlled trial, 184 female breast cancer patients are assigned to receive either SEPT, standard medical care or a manualized supportive therapy at the start of adjuvant endocrine treatment. SEPT consists of three sessions of cognitive-behavioral training including psychoeducation to provide a realistic view of endocrine therapy, imagination-training to integrate positive aspects of medication into daily life, and side-effect management to enhance expectations about coping ability. Side effects three months after the start of endocrine therapy serve as primary outcomes. Secondary outcomes include quality of life, coping ability and patients' medication adherence. Patients' expectations (i.e., expectations about side effects, coping ability, treatment and illness) are analyzed as mediators. Discussion: The optimization of expectations might be a potential pathway in health care to improve patients' quality of life during long-term medication intake. The results will provide implications for a possible integration of evidence-based prevention training into clinical practice.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trial
    Pia von Blanckenburg
    Franziska Schuricht
    Ute-Susann Albert
    Winfried Rief
    Yvonne Nestoriuc
    [J]. BMC Cancer, 13
  • [2] Optimizing expectations to prevent side effects of adjuvant endocrine treatment in breast cancer: A randomized controlled trial
    Shedden-Mora, M.
    Heisig, S.
    Von Blanckenburg, P.
    Witzel, I.
    Rief, W.
    Albert, U. S.
    Nestoriuc, Y.
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 2017, 97 : 167 - 168
  • [3] The effects of exercise on the quality of life of patients with breast cancer (the UMBRELLA Fit study): study protocol for a randomized controlled trial
    Gal, Roxanne
    Monninkhof, Evelyn M.
    Groenwold, Rolf H. H.
    van Gils, Carla H.
    van den Bongard, Desiree H. J. G.
    Peeters, Petra H. M.
    Verkooijen, Helena M.
    May, Anne M.
    [J]. TRIALS, 2017, 18
  • [4] The effects of exercise on the quality of life of patients with breast cancer (the UMBRELLA Fit study): study protocol for a randomized controlled trial
    Roxanne Gal
    Evelyn M. Monninkhof
    Rolf H. H. Groenwold
    Carla H. van Gils
    Desiree H. J. G. van den Bongard
    Petra H. M. Peeters
    Helena M. Verkooijen
    Anne M. May
    [J]. Trials, 18
  • [5] Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial
    Chalela, P.
    Munoz, E.
    Inupakutika, D.
    Kaghyan, S.
    Akopian, D.
    Kaklamani, V
    Lathrop, K.
    Ramirez, A.
    [J]. CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2018, 12 : 109 - 115
  • [6] OPTIMIZING EXPECTATIONS ABOUT ENDOCRINE TREATMENT FOR BREAST CANCER: RESULTS OF THE RANDOMIZED CONTROLLED PSY-BREAST TRIAL
    Shedden-Mora, Meike
    Pan, Yiqi
    Heisig, Sarah
    von Blanckenburg, Pia
    Rief, Winfried
    Witzel, Isabell
    Albert, Ute-Susann
    Nestoriuc, Yvonne
    [J]. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2018, 25 : S182 - S182
  • [7] Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial
    Schmidt, Martina E.
    Wiskemann, Joachim
    Armbrust, Petra
    Schneeweiss, Andreas
    Ulrich, Cornelia M.
    Steindorf, Karen
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (02) : 471 - 480
  • [8] Side effects of endocrine therapy in patients with breast cancer
    Douglas, SL
    Dillon, P
    Anderson, A
    Cameron, DA
    Leonard, T
    Leonard, RCF
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S313 - S314
  • [9] Effects of yoga program on quality of life and affect in early breast cancer patients undergoing adjuvant radiotherapy: A randomized controlled trial
    Vadiraja, H. S.
    Rao, M. Raghavendra
    Nagarathna, Raghuram
    Nagendra, H. R.
    Rekha, M.
    Vanitha, N.
    Gopinath, K. S.
    Srinath, B. S.
    Vishweshwara, M. S.
    Madhavi, Y. S.
    Ajaikumar, B. S.
    Bilimagga, S. Ramesh
    Rao, Nalini
    [J]. COMPLEMENTARY THERAPIES IN MEDICINE, 2009, 17 (5-6) : 274 - 280
  • [10] A Randomized Controlled Trial of the Effects of Transcendental Meditation on Quality of Life in Older Breast Cancer Patients
    Nidich, Sanford I.
    Fields, Jeremy Z.
    Rainforth, Maxwell V.
    Pomerantz, Rhoda
    Celia, David
    Kristeller, Jean
    Salerno, John W.
    Schneider, Robert H.
    [J]. INTEGRATIVE CANCER THERAPIES, 2009, 8 (03) : 228 - 234